SynthesisTouchREVIEWS in endocrinology2024

Efficacy and Safety of Novel Twincretin Tirzepatide, a Dual GIP/GLP-1 Receptor Agonist, as an Anti-obesity Medicine in Individuals Without Diabetes: A Systematic Review and Meta-analysis.

Deep Dutta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.